Care needed in interpretation of cancer survival measures
Menée en Angleterre et au Pays-de-Galles à partir des données des registres des cancers sur la période 1971-2011, cette étude analyse l'évolution de la survie des patients , par tranche d'âge et par localisation
Cancer patient survival obtained from population-based cancer studies is the optimum method to monitor and assess the effectiveness of patient care.1 Consideration of these estimates in conjunction with estimates of cancer incidence and mortality is still important.2 As a result, there is much interest in the assessment of progress in terms of cancer survival.3 and 4 Quantification of the improvements in cancer patient survival because of successes in some areas, such as treatment, diagnostic techniques, and awareness or screening campaigns, is of paramount importance to health-care officials, health policy makers, and charities supporting these developments in cancer control. However, to make a fair comparison—to compare like with like—is essential to assess progress accurately...
The Lancet , commentaire en libre accès, 2013